Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
5.83
+0.08 (1.39%)
At close: Jun 26, 2026, 4:00 PM EDT
5.85
+0.02 (0.34%)
After-hours: Jun 26, 2026, 7:52 PM EDT
Wave Life Sciences Stock Forecast
Stock Price Forecast
The 16 analysts with 12-month price forecasts for Wave Life Sciences stock have an average target of 24.13, with a low estimate of 13 and a high estimate of 43. The average target predicts an increase of 313.89% from the current stock price of 5.83.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Wave Life Sciences stock from 16 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 13 | 14 | 14 | 14 | 14 | 14 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 16 | 16 | 16 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho Securities | Mizuho Securities | Buy Maintains $27 | Buy | Maintains | $27 | +363.12% | Jun 12, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $13 | Buy | Reiterates | $13 | +122.98% | Jun 11, 2026 |
| Wedbush | Wedbush | Buy Maintains $15 | Buy | Maintains | $15 | +157.29% | May 27, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $43 | Buy | Maintains | $43 | +637.56% | May 20, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $13 → $14 | Buy | Reiterates | $13 → $14 | +140.14% | May 20, 2026 |
Financial Forecast
Revenue This Year
57.26M
from 42.73M
Increased by 34.01%
Revenue Next Year
51.52M
from 57.26M
Decreased by -10.03%
EPS This Year
-0.88
from -1.21
EPS Next Year
-1.11
from -0.88
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 99.0M | 151.0M | |
| Avg | 57.3M | 51.5M | |
| Low | 38.0M | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 131.7% | 163.7% | |
| Avg | 34.0% | -10.0% | |
| Low | -11.1% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.64 | -0.03 | |
| Avg | -0.88 | -1.11 | |
| Low | -1.33 | -1.78 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.